CPC C12N 5/0685 (2013.01) [A61K 9/0034 (2013.01); A61K 35/22 (2013.01); A61P 13/10 (2018.01); A61P 35/00 (2018.01); A61K 45/06 (2013.01)] | 5 Claims |
1. A method for treating a subject suffering from urothelial carcinoma, or bladder cancer, comprising administering intravesically to the subject an effective amount of a composition comprising xenogeneic urothelial cells in a solution wherein the xenogeneic urothelial cells are urothelial stem cells, urothelial progenitor cells, urothelial precursor cells and mature urothelial cells.
|